UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 402

Sortiert nach

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1395-1400

2013

Volltextzugriff (PDF)

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Leukemia, 2007-04, Vol.21 (4), p.627-632

2007

Volltextzugriff (PDF)

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1569-1572

2016

Volltextzugriff (PDF)

Agrarian Crossings: Reformers and the Remaking of the US and Mexican Countryside by Tore C. Olsson (review)

The Journal of southern history, 2018, Vol.84 (4), p.1022-1023

Ahlberg, Kristin L

2018

Volltextzugriff (PDF)

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Medical oncology (Northwood, London, England), 2014, Vol.31 (8), p.66-66, Article 66

2014

Volltextzugriff (PDF)

Inequalities in health: a comparative study between ethnic Norwegians and Pakistanis in Oslo, Norway

International journal for equity in health, 2006-06, Vol.5 (1), p.7-7, Article 7

2006

Volltextzugriff (PDF)

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

European journal of haematology, 2019-08, Vol.103 (2), p.88-98

2019

Volltextzugriff (PDF)

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Leukemia, 2008-02, Vol.22 (2), p.462-462

2008

Volltextzugriff (PDF)

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

European journal of haematology, 2017-08, Vol.99 (2), p.141-149

2017

Volltextzugriff (PDF)

Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial

Cancer chemotherapy and pharmacology, 2018-01, Vol.81 (1), p.183-193

2018

Volltextzugriff (PDF)

"Machiavelli with a Heart": The Johnson Administration's Food for Peace Program in India, 1965–1966

Diplomatic history, 2007-09, Vol.31 (4), p.665-701

AHLBERG, KRISTIN L.

2007

Volltextzugriff (PDF)

Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice

European journal of haematology, 2018-10, Vol.101 (4), p.556-565

2018

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

Leukemia, 2012-05, Vol.26 (5), p.972-976

2012

Volltextzugriff (PDF)

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

Leukemia & lymphoma, 2018-10, Vol.59 (10), p.2470-2473

2018

Volltextzugriff (PDF)

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

European journal of haematology, 2014, Vol.92 (5), p.377-381

2014

Volltextzugriff (PDF)

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

BLOOD, 2015-12, Vol.126 (23), p.3047-3047

2015

Volltextzugriff (PDF)

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003–2007

Haematologica (Roma), 2012-09, Vol.97 (9), p.1414-1421

2012

Volltextzugriff (PDF)

Building a Model Public History Program: The Office of the Historian at the U.S. Department of State

The Public historian, 2008-05, Vol.30 (2), p.9-28

AHLBERG, KRISTIN L.

2008

Volltextzugriff (PDF)

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

BLOOD, 2013-11, Vol.122 (21), p.1972-1972

2013

Volltextzugriff (PDF)

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation

Haematologica (Roma), 2006-09, Vol.91 (9), p.1228-1233

2006

Volltextzugriff (PDF)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma

Cancer medicine (Malden, MA), 2018-06, Vol.7 (6), p.2256-2268

2018

Volltextzugriff (PDF)

Reagan on War: A Reappraisal of the Weinberger Doctrine, 1980‐1984. By Gail E. S.Yoshitani. College Station: Texas A & M University Press, 2012. 250 pp

Presidential studies quarterly, 2014-09, Vol.44 (3), p.570-571

Ahlberg, Kristin L.

2014

Volltextzugriff (PDF)

1 – 25 von 402

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(360)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009

Agrarian Crossings: Reformers and the Remaking of the US and Mexican Countryside by Tore C. Olsson (review)

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Inequalities in health: a comparative study between ethnic Norwegians and Pakistanis in Oslo, Norway

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial

"Machiavelli with a Heart": The Johnson Administration's Food for Peace Program in India, 1965–1966

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT

Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003–2007

Building a Model Public History Program: The Office of the Historian at the U.S. Department of State

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma

Reagan on War: A Reappraisal of the Weinberger Doctrine, 1980‐1984. By Gail E. S.Yoshitani. College Station: Texas A & M University Press, 2012. 250 pp

Suchergebnisse filtern